Mono-N-alkylation of anthranilamides via quinazolinones. An efficient synthesis of G5598, a benzodiazepine dione gpIIbIIIa antagonist
摘要:
The mono-N-alkylation of an anthranilamide derivative via the reductive ring opening of a quinazolinone precursor, enables the synthesis of benzodiazepine dione derivative G5598, a potent inhibitor of the in vitro binding of GpIIbIIIa to fibrinogen.
[EN] NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR
申请人:GENENTECH, INC.
公开号:WO1993008174A1
公开(公告)日:1993-04-29
(EN) A benzodiazepinedione derivative which acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPIIbIIIa receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.(FR) Un dérivé de benzodiazépinedione intervient en tant qu'inhibiteur non peptidyle d'aggrégation des plaquettes. Il inhibe fortement la liaison des fibrinogènes au récepteur GPIIbIIIa et figure dans des compositions thérapeutiques relatives au traitement de maladies pour lesquelles il convient de bloquer l'aggrégation des plaquettes. Ces inhibiteurs non peptidyles sont combinés avec des thrombolytiques et des anticoagulants.